UK-based CBD brand Naturecan acquires Oregon production facility
United Kingdom-based CBD and wellness brand Naturecan acquired the IAH Oregon cannabidiol production facility in the U.S. for 8 million pounds (roughly $10 million).
Cannabis extraction company and product news, how-tos
United Kingdom-based CBD and wellness brand Naturecan acquired the IAH Oregon cannabidiol production facility in the U.S. for 8 million pounds (roughly $10 million).
Vape hardware manufacturer Greentank Technologies closed a Series B financing round worth $16.5 million with an unspecified “strategic investor group” that includes Canadian cannabis producer Organigram Holdings.
Potency testing on store-bought cannabis flower by a Canadian laboratory has found THC levels significantly lower than the labeled value, sparking an industrywide conversation about how to address inaccurate THC claims.
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.
While some marijuana companies are exiting California’s difficult, regulated market – Curaleaf Holdings is among the most notable – others big and small are staying focused on the state and have plans to grow in 2023.
Efforts to cap the potency of cannabis products in Washington state and limit high-potency THC to the medical marijuana market appear to have failed.
British Columbia-based cannabis company Adastra Labs has been approved by Health Canada to possess, produce, sell and distribute cocaine, psilocybin and psilocin.